Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell ...

A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized ...

The identification of CD8+ TIGR cells yields new insights into organ-specific immune regulation and potential therapeutics for inflammatory bowel disease.

Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...

Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward ...

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) caused by chronic inflammation. It is the leading cause of neurologic symptoms in young people and leads to ...

A collaborative effort among researchers at the Henan Academy of Innovations in Medical Science, Zhengzhou University, and Shenzhen University School of Medicine has provided the first ...

Findings support the potential of SRC-3 gene disrupted regulatory T cells to expand the therapeutic impact of next-generation cell therapies HOUSTON, March 17, 2026 (GLOBE NEWSWIRE)-- CoRegen, Inc., a ...

Scientists have uncovered new genetic rules that determine whether the immune system’s “killer” T cells remain powerful long-term defenders or become worn out and ineffective. By building a detailed ...

A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has developed a new class of engineered extracellular vesicles (EVs) capable of ...